- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 1/107 - General processes for the preparation of peptides by chemical modification of precursor peptides
Patent holdings for IPC class C07K 1/107
Total number of patents in this class: 1198
10-year publication summary
|
62
|
67
|
62
|
71
|
69
|
79
|
71
|
89
|
118
|
70
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20211 |
28 |
| Forschungsverbund Berlin e.V. | 194 |
17 |
| Ludwig-Maximilians-Universitat Munchen | 342 |
15 |
| Janssen Pharmaceutica N.V. | 3352 |
14 |
| Bristol-myers Squibb Company | 4847 |
13 |
| Massachusetts Institute of Technology | 10131 |
13 |
| President and Fellows of Harvard College | 6017 |
13 |
| Quiapeg Pharmaceuticals AB | 45 |
13 |
| Pfizer Inc. | 3388 |
11 |
| Takeda Pharmaceutical Company Limited | 2713 |
10 |
| Bicyclerd Limited | 148 |
10 |
| New York University | 1755 |
9 |
| Novo Nordisk A/S | 2273 |
9 |
| F. Hoffmann-La Roche AG | 7944 |
8 |
| Amgen Inc. | 4147 |
8 |
| NBE Therapeutics AG | 38 |
8 |
| Roche Sequencing Solutions, Inc. | 665 |
8 |
| Aileron Therapeutics, Inc. | 80 |
7 |
| Hybio Pharmaceutical Co., Ltd. | 121 |
7 |
| Universiteit Gent | 1354 |
7 |
| Other owners | 970 |